Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.
about
Magnesium for treating sickle cell diseaseGenetic determinants of haemolysis in sickle cell anaemia.Magnesium for treating sickle cell diseaseShort- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?Molecular controls of the oxygenation and redox reactions of hemoglobinVasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses.Clinical biomarkers in sickle cell disease.Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportFrequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammationCirculating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.Low forced expiratory volume is associated with earlier death in sickle cell anemiaHemoglobin sickle cell disease complications: a clinical study of 179 casesFree hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.Sickle Cell Hemoglobin in the Ferryl State Promotes βCys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10)Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteinsAn Overview of Fractional Exhaled Nitric Oxide and Children with AsthmaThe relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeIn vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell diseaseHemodynamic predictors of mortality in adults with sickle cell diseaseHematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.Extracellular hemin crisis triggers acute chest syndrome in sickle miceAsthma management in sickle cell diseaseCardiovascular abnormalities in sickle cell disease.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?Pathophysiological insights in sickle cell disease.Biomarkers in sickle cell disease.Role of oxidative stress in the pathogenesis of sickle cell disease.Management of sickle cell disease in the community.Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.Intravascular hemolysis and the pathophysiology of sickle cell disease.Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.
P2860
Q24193246-38BEBC5F-5EBD-4783-A827-A7C41FA97A2AQ29417116-0C9E2617-6596-4502-8879-B986EDC25215Q29994630-F1EA4E38-251E-4B0E-99C5-E2F7967A0AB6Q33401130-235484E9-92B3-43B2-A591-AFD0FA1D5808Q33720622-D4060ED1-8EE6-49BC-A6B9-CBF559377A95Q34665207-54160174-6557-4288-A33A-7BD39F9E8E6FQ34800466-ECC30060-C9FF-42CC-9236-B6B357B76401Q35243386-A2BE60E1-9DE1-49E4-84A7-0149D5BF5855Q35288031-E8926FE6-C1E4-43E8-B988-FF62A8AD4A7AQ35346284-86819E3A-16BD-4622-A99B-8ECF3BAF6DA4Q35528598-C7D2104C-1BB9-4A17-8AF6-52F0EDACD005Q35813199-CF3331B4-9BF3-40DA-94E4-327D4CBA9465Q35881838-1A6F4B53-DC6C-4E0A-8B75-B1AD32C3DDB3Q35925616-B33C6C71-7110-44B4-9C37-4F49D73D736EQ36091274-C746EE4B-840B-4B38-A20E-CEB84E3DCEF2Q36132987-1DB11EBB-79C6-499A-AF75-46A623800A91Q36178065-F4EBB42A-9C12-468F-BC85-7847189247EFQ36282955-54B4A441-DC9A-419A-BE86-E276B24B5294Q36628281-A68F7467-6E3C-423A-A7A1-687B8236B368Q36814010-A0AC5A2E-7B9F-4B73-8FA8-E23830CA6858Q36862364-F4339C76-5C54-4964-8201-2CADFACA3B16Q36941158-33716824-BC29-4CA1-A6E7-E0755A678385Q36967104-6C638DEA-E35C-46C2-AC5C-346271F03DB0Q36999803-8E1C45D6-3E66-4182-A246-A2DF7B7F5131Q37154176-9F331B28-BE2B-46CD-8B1C-4A335E4183A4Q37258558-FDA1F2E9-4962-4649-8DA4-AC0DF7AF0B2CQ37259191-B408AA06-6767-442D-8045-4AB6FCC3A798Q37346672-98B9ECC8-96AF-412B-99B2-A49865900EAAQ37435068-BAF5BBE4-D04F-4C86-A61B-07A15ACA9A45Q37565002-B631C5C2-D77C-4555-9BD9-70AF1E0A9742Q37636986-040C6DBD-D863-40D4-9724-3A4020C91ECCQ37729403-FAA87B74-FFB6-416F-9FCC-3D9A195FDC31Q37956958-33E4BA7A-DA7A-4E61-B411-BBD2985C84A7Q37961814-AAC85C71-7CEC-4C47-BACC-D7FE45A51D19Q37963311-97FED6F9-700E-4B3E-8F0A-918A2A859313Q38194789-7288CE4B-581E-4828-B6CF-4B18A07FB801Q38837694-9352390F-19A2-48C5-8AD6-B1ABC0CC699DQ38853641-177B8CAB-647B-40D0-862D-65164AFDF093Q39156028-152BDBA4-77B6-4FA1-9BDD-96F69D4B74A1Q39806047-0302005D-144F-49F6-9F3F-230C3AB59191
P2860
Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@ast
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@en
type
label
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@ast
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@en
prefLabel
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@ast
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@en
P2860
P356
P1476
Reconstructing sickle cell dis ...... ve of evidence-based medicine.
@en
P2093
Robert P Hebbel
P2860
P304
P356
10.1002/AJH.21952
P577
2011-02-01T00:00:00Z